Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Keller

Showing results (31-40 of 94) with videos related to

Pageof 10
Sort By:
Cutis|April 12, 2017
Imatinib mesylate-induced lichenoid drug eruptionErin H Penn, Hye Jin Chung, Matthew Keller
Cutis|October 4, 2014
Rupioid psoriasis and other skin diseases with rupioid manifestationsHye J Chung, Daria Marley-Kemp, Matthew Keller
Dermatology Online Journal|February 16, 2018
Modernizing dermatology interest groups in medical school: Certificate programsJordan V Wang, Dorota Z Korta, Matthew Keller
Skinmed|November 23, 2016
Desquamative Dermatitis Caused by Erlotinib: An Underreported Cutaneous Adverse EventMiriam L Vega, Natalie C Yin, Matthew Keller
Nature|June 2, 2026
Is it time to 'cap and trade' credits for research-funding proposals?Neil M Davies, David Bann, Matthew Keller, et al.
Skinmed|January 7, 2020
Uncovering Unconscious Bias and Health Disparities in the Practice of DermatologyElizabeth Schoenberg, Jordan V Wang, Robert Duffy, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|July 21, 2017
Surgical Emphysema Following Canalplasty for Aural ExostosesMichael C Baxter, Matthew Keller, Anil Shah, et al.
The American Journal of Emergency Medicine|October 8, 2021
Equal incidence of COVID-19 among homeless and non-homeless ED patients when controlling for confoundersMatthew Keller, Jacob Shreffler, Kathleen Wilmes, et al.
The American Journal of Emergency Medicine|November 29, 2021
The authors respond: The impact of COVID 19 on homeless individualsMatthew Keller, Jacob Shreffler, Kathleen Wilmes, et al.
Oncogene|September 26, 2003
Cdx1 inhibits the proliferation of human colon cancer cells by reducing cyclin D1 gene expressionJohn Lynch, Matthew Keller, Rong-Jun Guo, et al.
Pageof 10

Showing results (31-40 of 94) with videos related to

Sort By:
Pageof 10
Cutis|April 12, 2017
Imatinib mesylate-induced lichenoid drug eruptionErin H Penn, Hye Jin Chung, Matthew Keller
Cutis|October 4, 2014
Rupioid psoriasis and other skin diseases with rupioid manifestationsHye J Chung, Daria Marley-Kemp, Matthew Keller
Dermatology Online Journal|February 16, 2018
Modernizing dermatology interest groups in medical school: Certificate programsJordan V Wang, Dorota Z Korta, Matthew Keller
Skinmed|November 23, 2016
Desquamative Dermatitis Caused by Erlotinib: An Underreported Cutaneous Adverse EventMiriam L Vega, Natalie C Yin, Matthew Keller
Nature|June 2, 2026
Is it time to 'cap and trade' credits for research-funding proposals?Neil M Davies, David Bann, Matthew Keller, et al.
Skinmed|January 7, 2020
Uncovering Unconscious Bias and Health Disparities in the Practice of DermatologyElizabeth Schoenberg, Jordan V Wang, Robert Duffy, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|July 21, 2017
Surgical Emphysema Following Canalplasty for Aural ExostosesMichael C Baxter, Matthew Keller, Anil Shah, et al.
The American Journal of Emergency Medicine|October 8, 2021
Equal incidence of COVID-19 among homeless and non-homeless ED patients when controlling for confoundersMatthew Keller, Jacob Shreffler, Kathleen Wilmes, et al.
The American Journal of Emergency Medicine|November 29, 2021
The authors respond: The impact of COVID 19 on homeless individualsMatthew Keller, Jacob Shreffler, Kathleen Wilmes, et al.
Oncogene|September 26, 2003
Cdx1 inhibits the proliferation of human colon cancer cells by reducing cyclin D1 gene expressionJohn Lynch, Matthew Keller, Rong-Jun Guo, et al.
Pageof 10